| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |